|
"高嘉宏"的相關文件
顯示項目 216-225 / 491 (共50頁)
<< < 17 18 19 20 21 22 23 24 25 26 > >>
每頁顯示[10|25|50]項目
| 國立臺灣大學 |
2012 |
Serum interleukin 6 level correlates with outcomes of acute exacerbation of chronic hepatitis B
|
Pan, Corinna Jen-Hui; Wu, Hui-Lin; Kuo, Stephanie Fang-Tzu; Kao, Jia-Horng; Tseng, Tai-Chung; Liu, Chen-Hua; Chen, Pei-Jer; Liu, Chun-Jen; Chen, Ding-Shinn; 陳定信; 劉振驊; 高嘉宏; 劉俊人; 陳培哲 |
| 國立臺灣大學 |
2012 |
Genomic variation-guided management in chronic hepatitis C
|
Hsu, Ching-Sheng; Kao, Jia-Horng; 高嘉宏 |
| 國立臺灣大學 |
2012 |
Non-alcoholic fatty liver disease: An emerging liver disease in Taiwan
|
Hsu, Ching-Sheng; Kao, Jia-Horng; 高嘉宏 |
| 國立臺灣大學 |
2012 |
Young Chronic Hepatitis B Patients With Nucleos(t)ide Analogue-induced Hepatitis B e Antigen Seroconversion Have a Higher Risk of HBV Reactivation
|
Tseng, Tai-Chung; Liu, Chun-Jen; Su, Tung-Hung; Yang, Hung-Chih; Wang, Chia-Chi; Chen, Chi-Ling; Kuo, Stephanie Fang-Tzu; Liu, Chen-Hua; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 劉俊人; 陳培哲 |
| 國立臺灣大學 |
2012 |
SUSTAINED HCV CLEARANCE AND INCREASED HBSAG SEROCLEARANCE IN PATIENTS WITH DUAL CHRONIC HEPATITIS C AND B POST-PEGINTERFERON ALFA-2A AND RIBAVIRIN TREATMENT: A 5-YEAR FOLLOW-UP
|
Liu, C. -J.; Chuang, W. -L.; Lee, C. -M.; Yu, M. -L.; Lu, S. -N.; Wu, S. -S.; Liao, L. -Y.; Chen, C. -L.; Kuo, H. -T.; Chao, Y. -C.; Tung, S. -Y.; Yang, S. -S.; Kao, J. -H.; Liu, C. -H.; Su, W. -W.; Lin, C. -L.; Chen, P. -J.; Chen, D. -S.; 陳定信; 劉振驊; 高嘉宏; 劉俊人; 陳培哲; 陳祈玲 |
| 國立臺灣大學 |
2012 |
Severity of fatty liver on ultrasound correlates with metabolic and cardiovascular risk
|
Wang, Chia-Chi; Tseng, Tai-Chung; Hsieh, Tsung-Cheng; Hsu, Ching-Sheng; Wang, Pin-Chao; Lin, Hans Hsienhong; Kao, Jia-Horng; 高嘉宏 |
| 國立臺灣大學 |
2012 |
ALISPORIVIR (ALV) PLUS PEG-INTERFERON/RIBAVIRIN (PR) IN HCV G1 TREATMENT-EXPERIENCED PATIENTS ACHIEVES PRIMARY ENDPOINT WITH SUPERIOR EFFICACY AT TREATMENT WEEK 12 COMPARED TO RETREATMENT WITH PR
|
Alberti, A.; Chuang, W. -L.; Flisiak, R.; Mazzella, G.; Horban, A.; Goeser, T.; Calistru, P.; Buti, M.; Davis, G.; Gong, Y.; Avila, C.; Kao, J. -H.; 高嘉宏 |
| 國立臺灣大學 |
2012 |
APASL consensus statements and management algorithms for hepatitis C virus infection
|
Omata, Masao; Kanda, Tatsuo; Yu, Ming-Lung; Yokosuka, Osamu; Lim, Seng-Gee; Jafri, Wasim; Tateishi, Ryosuke; Hamid, Saeed S.; Chuang, Wan-Long; Chutaputti, Anuchit; Wei, Lai; Sollano, Jose; Sarin, Shiv Kumar; Kao, Jia-Horng; McCaughan, Geoffrey W.; 高嘉宏 |
| 國立臺灣大學 |
2012 |
Profiles and Clinical Significance of HBsAg Titer in Patients Receiving Peginterferon Alfa-2a plus Ribavirin for the Treatment of Dual Chronic Infection with Hepatitis B and C Viruses
|
Liu, Chun-Jen; Yu, Ming-Lung; Lee, Chuan-Mo; Chen, Chi-Ling; Chuang, Wan-Long; Wu, Shun-Sheng; Yang, Sien-Sing; Kao, Jia-Horng; Lin, Chih-Lin; Chen, Pei-Jer; Chen, Ding-Shinn; 陳定信; 高嘉宏; 劉俊人; 陳培哲; 陳祈玲 |
| 國立臺灣大學 |
2012 |
Dynamic changes of precore and basal core promoter mutations in HBeAg-positive chronic hepatitis B patients receiving interferon therapy
|
Yang, Hung-Chih; Chen, Chi-Ling; Shen, Yueh-Chi; Peng, Cheng-Yuan; Liu, Chun-Jen; Tseng, Tai-Chung; Su, Tung-Hung; Chuang, Wan-Long; Yu, Ming-Lung; Dai, Chia-Yen; Liu, Chen-Hua; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; 陳定信; 劉振驊; 高嘉宏; 蘇東弘; 劉俊人; 陳培哲; 陳祈玲 |
顯示項目 216-225 / 491 (共50頁)
<< < 17 18 19 20 21 22 23 24 25 26 > >>
每頁顯示[10|25|50]項目
|
